COMPLETE GENOMICS, INC. Inactive Instrument
Complete Genomics, Inc. Stock
Equities
US20454K1043
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
More press releases
More news
| Director | Title | Age | Since |
|---|---|---|---|
Xun Xu
CEO | Chief Executive Officer | - | - |
Radoje Drmanac
CTO | Chief Tech/Sci/R&D Officer | 66 | 2005-12-31 |
Robert Curson
PRN | Corporate Officer/Principal | 81 | 2010-11-15 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -2.56% | +1.67% | +30.18% | -11.70% | 38.5B | ||
| +2.59% | +17.33% | +203.92% | +363.83% | 17.57B | ||
| +0.22% | +3.71% | +119.33% | +38.07% | 5.14B | ||
| +0.28% | -1.18% | +37.47% | -74.46% | 2.13B | ||
| -2.22% | +1.44% | -13.67% | -37.43% | 1.83B | ||
| -2.26% | -12.93% | -57.82% | -59.08% | 1.32B | ||
| +2.65% | -11.43% | -28.41% | - | 1.24B | ||
| +2.95% | +5.87% | -24.97% | -41.53% | 1.15B | ||
| +1.35% | +7.37% | - | - | 722M | ||
| Average | +0.30% | +1.31% | +33.26% | +25.39% | 7.73B | |
| Weighted average by Cap. | -0.75% | +6.27% | +76.54% | +85.53% |
- Stock Market
- Equities
- Stock